These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A central role for JNK in obesity and insulin resistance. Hirosumi J; Tuncman G; Chang L; Görgün CZ; Uysal KT; Maeda K; Karin M; Hotamisligil GS Nature; 2002 Nov; 420(6913):333-6. PubMed ID: 12447443 [TBL] [Abstract][Full Text] [Related]
25. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
26. [Insulin resistance in spontaneous obesity. Role of insulin receptors]. Pagano G; Cassader M Minerva Dietol Gastroenterol; 1979; 25(3):265-74. PubMed ID: 554018 [No Abstract] [Full Text] [Related]
27. Obesity and pregnancy--the propagation of a viscous cycle? Catalano PM J Clin Endocrinol Metab; 2003 Aug; 88(8):3505-6. PubMed ID: 12915626 [No Abstract] [Full Text] [Related]
28. Osteopontin in the pathophysiology of obesity: Is Opn a fat cell foe? Fitter S; Zannettino ACW Obes Res Clin Pract; 2018; 12(3):249-250. PubMed ID: 29914635 [No Abstract] [Full Text] [Related]
29. Obesity and insulin resistance: an ongoing saga. Kim SH; Reaven G Diabetes; 2010 Sep; 59(9):2105-6. PubMed ID: 20805385 [No Abstract] [Full Text] [Related]
30. Not all fat is alike. Arner P Lancet; 1998 May; 351(9112):1301-2. PubMed ID: 9643790 [No Abstract] [Full Text] [Related]
31. Response to letter to the editor. Fernández-Real JM J Clin Endocrinol Metab; 2015 Jan; 100(1):L17. PubMed ID: 25559541 [No Abstract] [Full Text] [Related]
32. Clinical review 26: Insulin resistance in obese and nonobese man. Caro JF J Clin Endocrinol Metab; 1991 Oct; 73(4):691-5. PubMed ID: 1890146 [No Abstract] [Full Text] [Related]
33. Prevalence and time trends of obesity in Europe. Seidell JC J Endocrinol Invest; 2002 Nov; 25(10):816-22. PubMed ID: 12508944 [No Abstract] [Full Text] [Related]
34. Letter to the Editor From Asadipooya: "Obesity and COVID-19: Mechanistic Insights From Adipose Tissue". Asadipooya K J Clin Endocrinol Metab; 2022 Sep; 107(10):e4269. PubMed ID: 35907180 [No Abstract] [Full Text] [Related]
35. Response to Letter to the Editor From Asadipooya: "Obesity and COVID-19: Mechanistic Insights From Adipose Tissue". Yu L; Ye J J Clin Endocrinol Metab; 2022 Sep; 107(10):e4274-e4275. PubMed ID: 35907184 [No Abstract] [Full Text] [Related]
36. From the editor: What is obesity? Brown WV J Clin Lipidol; 2013; 7(4):289-90. PubMed ID: 23890515 [No Abstract] [Full Text] [Related]
37. Obesity: the two faces of fat. Powell K Nature; 2007 May; 447(7144):525-7. PubMed ID: 17538594 [No Abstract] [Full Text] [Related]
38. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Després JP Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095 [No Abstract] [Full Text] [Related]